Target Poor or Non Binder(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T95923 | Target Info | |||
Target Name | Lysophosphatidate-3 receptor (LPAR3) | ||||
Synonyms |
Lysophosphatidic acid receptor Edg7; Lysophosphatidic acid receptor 3; LPAR3; LPA3; LPA receptor 3
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | LPAR3 | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Poor Binders of This Target (in total, 2 binders) | Download | Top | |||
---|---|---|---|---|---|
Compound Name |
LPA2 antagonist 1
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL256470; VC-6664; BCP11072; BDBM50373826; MFCD25976928; ZINC29126798; NCGC00390601-01; HY-18075
Click to Show/Hide
|
||||
Activity |
IC50 ~ 50000 nM
|
[1] | |||
Compound Name |
7-Methyl-N-[(2S)-1-[4-(2-methylphenyl)piperazin-1-yl]propan-2-yl]thieno[3,2-d]pyrimidin-4-amine
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL404452; BDBM50373817
Click to Show/Hide
|
||||
Activity |
IC50 ~ 50000 nM
|
[1] |
Non Binders of This Target (in total, 2 non binders) | Download | Top | |||
---|---|---|---|---|---|
Compound Name |
[(3R)-1-Fluoro-3-hydroxy-4-[(E)-octadec-9-enoyl]oxybutyl]phosphonic acid
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL370500
Click to Show/Hide
|
||||
Activity |
EC50 ~ 500000 nM
|
[2] | |||
Compound Name |
[(3S)-1,1-Difluoro-3-hydroxy-4-[(E)-octadec-9-enoyl]oxybutyl]phosphonic acid
Click to Show/Hide
|
Investigative | Compound Info | ||
Synonyms |
CHEMBL426633
Click to Show/Hide
|
||||
Activity |
EC50 ~ 500000 nM
|
[2] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1037-41. | ||||
REF 2 | Structure-activity relationships of fluorinated lysophosphatidic acid analogues. J Med Chem. 2005 May 5;48(9):3319-27. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.